Laboratories
Home > Laboratories > Brain Science Institute > Disease Mechanism Research Core > Laboratory for Molecular Psychiatry
Laboratory for Molecular Psychiatry
Takeo YOSHIKAWA
Laboratory Head
Takeo YOSHIKAWA (M.D., Ph.D.)
mail

Click

Research Areas

Endogenous or functional psychoses, such as schizophrenia and mood disorders, are relatively common diseases that show a chronic course. Once the disease develops, the patient's quality of life deteriorates substantially. This is because there are no ideal medical treatments, a reflection of the largely unknown etiology of these illnesses. Considering the immense personal and social loss induced by mental disorders, it is imperative to identify the mechanisms of the diseases, so as to develop fundamental therapies and effective prevention. Our current efforts focus on strategies that aim to identify susceptibility genes for psychiatric disorders, by employing molecular and behavioral genetic approaches that utilize both human samples and animal models. We hope that these endeavors will lead to a better understanding of neuropsychiatric diseases at the molecular level and eventually contribute to improving the welfare of patients suffering from these disorders.

Research Subject

  1. Genetic analyses of schizophrenia, mood disorders and autism
  2. Studies on animal models (transgenic and knock out mice, and environmental factors)

Related links

  1. RIKEN Brain Science Institute Website_Laboratories PageNew Window
  2. Individual Website Laboratory PageNew Window

Press release

April 08, 2009
Arachidonic acid may promote neurogenesis and thus prevent mental disorder
November 13, 2007
A Candidate Gene for a Biological Marker of Schizophrenia in MiceNew Window
February 20, 2007
Joint research between Molecular Psychiatry of BSI and the RIKEN-MIT Neuroscience Research Center has identified genes causative to schizophrenia

RIKEN RESEARCH

February 29, 2008
Seeking schizophrenia genes
Researchers map genetic alterations associated with human schizophreniaNew Window
May 16, 2007
New suspected causes of schizophrenia
Genetic research uncovers more candidate schizophrenia genesNew Window

List of Selected Publications

  1. Maekawa, M., Fujisawa, H., Iwayama, Y., Tamase, A., Toyota, T., Osumi, N., Yoshikawa, T.:
    "Giant subependymoma developed in a patient with aniridia: analyses of PAX6 and Tumor relevant genes"
    Brain Pathology 20, 1033-1041 (2010)
  2. Arai, M,, Yuzawa, H., Nohara, .I, Ohnishi, T., Obata, N., Iwayama, Y., Haga, S., Toyota, T., Ujike, H., Ichikawa, T., Tanaka, Y., Furukawa, A., Aikawa, Y., Kuroda, O., Niizato, K., Izawa, R., Nakamura, K., Mori, N., Matsuzawa, D., Hashimoto, K., Iyo, M., Sora, I., Matsushita, M., Okazaki, Y., Yoshikawa, T., Miyata, T., Itokawa, M.:
    "Enhanced carbonyl stress in a subpopulation of schizophrenia"
    Archives of General Psychiatry 67, 598-607 (2010)
  3. Watanabe, A., Toyota, T., Owada, Y., Hayashi, T., Iwayama, Y., Matsumata, M., Ishitsuka, Y., Nakaya, A., Maekawa, M., Ohnishi, T., Arai, R., Sakurai, K., Yamada, K., Kondo, H., Hashimoto, K., Osumi, N., Yoshikawa, T.:
    "Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype"
    PLoS Biology 5, e297 (2007)
  4. Yamada, K., Gerber, D.J., Iwayama, Y., Ohnishi, T., Ohba, H., Toyota, T., Aruga, J., Minabe, Y., Tonegawa, S., Yoshikawa, T.:
    "Genetic analysis of the calcineurin pathway identifies the EGR family and specifically EGR3, as potential candidates in schizophrenia"
    Proc. Natl. Acad. Sci. USA 104, 2815-2820 (2007)
  5. Nakatani, N., Hattori, E., Ohnishi, T., Dean, B., Iwayama, Y., Matsumoto, I., Kato, T., Osumi, N., Higuchi, T., Niwa, S., Yoshikawa, T.:
    "Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation"
    Hum. Mol. Genet. 15, 1949-1962 (2006)
  6. Yamada, K., Ohnishi, T., Hashimoto, K., Ohba, H., Iwayama-Shigeno, Y., Toyoshima, M., Okuno, A., Takao, H., Toyota, T., Minabe, Y., Nakamura, K., Shimizu, E., Itokawa, M., Mori, N., Iyo, M. Yoshikawa. T.:
    "Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels"
    Biol. Psychiatry 57. 1493-1503 (2005)
  7. Toyota, T., Yoshitsugu, K., Ebihara, M., Yamada, K., Ohba, H., Fukasawa, M., Minabe, Y., Nakamura, K., Sekine, Y., Takei, N., Suzuki, K., Itokawa, M., Meerabux, J.M.A., Iwayama-Shigeno, Y., Tomaru, Y., Shimizu, H., Hattori, E., Mori, N., and Yoshikawa, T.:
    "Association between schizophrenia with ocular misalignment and polyalanine length variation in PMX2B"
    Hum. Mol. Genet. 13, 551-561 (2004)
  8. Nakatani, N., Aburatani, H., Nishimura, K., Semba, J., and Yoshikawa, T.:
    "Comprehensive expression analysis of a rat depression model"
    Pharmacogenomics J. 4, 114-126 (2004)
  9. Itokawa, M., Yamada, K., Yoshitsugu, K., Toyota, T., Suga, T., Ohba, H., Watanabe, A., Hattori, E., Shimizu, H., Kumakura, T., Ebihara, M., Meerabux, J.M.A., Toru, M., and Yoshikawa, T.:
    "A microsatellite repeat in the promoter of the NMDA receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia"
    Pharmacogenetics 13, 271-278 (2003).
  10. Yoshikawa, T., Watanabe, A., Ishitsuka, Y., Nakaya, A., and Nakatani, N.:
    "Identification of multiple genetic loci linked to the propensity for behavioral despair in mice"
    Genome Research 12, 357-366 (2002)